The effects of tranexamic acid in patients treated with extracorporeal membrane oxygenation after cardiac surgery

被引:2
|
作者
Chen, Wei [1 ]
Du, Zhongtao [1 ]
Wang, Liangshan [1 ]
Wang, Mengjun [1 ]
Wang, Hong [1 ]
Hou, Xiaotong [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Ctr Cardiac Intens Care, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Anzhen Hosp, Ctr Cardiac Intens Care, Beijing 100029, Peoples R China
来源
PERFUSION-UK | 2025年 / 40卷 / 02期
关键词
tranexamic acid; cardiac surgery; extracorporeal membrane oxygenation; TRANSFUSION; COMPLICATIONS; HEMORRHAGE; EVENTS;
D O I
10.1177/02676591241242641
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The lysine analog tranexamic acid (TXA) is used as a blood protective drug in cardiac surgery, but efficacy and safety outcomes in patients treated with extracorporeal membrane oxygenation (ECMO) after surgery remain poorly understood. Methods From January 1, 2017 to December 31, 2022, we retrospectively analyzed patients assisted by ECMO after cardiac surgery and divided them into TXA and control groups depending on whether TXA was used or not. The primary study outcome was red blood cell (RBC) transfusion during ECMO. Results In total, 321 patients treated with ECMO after cardiac surgery were assessed; 185 patients were eligible for inclusion into to the TXA-intervention group and 136 into to the control group. RBC transfusion during ECMO was 8.0 IU (4.0 IU-14.0 IU) in the TXA group versus 10.0 IU (6.0 IU-16.0 IU) in the control group (p = .034). Median total chest drainage volume after surgery was 1460.0 mL (650.0-2910.0 mL) and 1680.0 mL (900.0-3340.0 mL) in TXA and control groups, respectively (p = .021). Postoperative serum D-dimer levels were significantly lower in the TXA group when compared with the control group; 1.125 mu g/mL (0.515-2.176 mu g/mL) versus 3.000 mu g/mL (1.269-5.862 mu g/mL), p < .001. Serious adverse events, including vascular occlusive events, did not differ meaningfully between groups. Conclusions In patients treated with ECMO after cardiac surgery, TXA infusion modestly but significantly reduced RBC transfusions and chest tube output when compared with the control group.
引用
收藏
页码:475 / 482
页数:8
相关论文
共 50 条
  • [31] Outcome-associated factors in pediatric patients treated with extracorporeal membrane oxygenator after cardiac surgery
    Kulik, TJ
    Moler, FW
    Palmisano, JM
    Custer, JR
    Mosca, RS
    Bove, EL
    Bartlett, RH
    CIRCULATION, 1996, 94 (09) : 63 - 68
  • [32] Appropriate timing of veno-arterial extracorporeal membrane oxygenation initiation after cardiac surgery
    Laimoud, Mohamed
    Hakami, Emad
    Machado, Patricia
    Lo, Michelle Gretchen
    Maghirang, Mary Jane
    CARDIOTHORACIC SURGEON, 2024, 32 (01):
  • [33] Delayed extracorporeal membrane oxygenation in children after cardiac surgery: two-institution experience
    Gupta, Punkaj
    DasGupta, Rahul
    Best, Derek
    Chu, Craig B.
    Elsalloukh, Hassan
    Gossett, Jeffrey M.
    Imamura, Michiaki
    Butt, Warwick
    CARDIOLOGY IN THE YOUNG, 2015, 25 (02) : 248 - 254
  • [34] Neuropsychological abilities of children with cardiac disease treated with extracorporeal membrane oxygenation
    Tindall, S
    Rothermel, RR
    Delamater, A
    Pinsky, W
    Klein, MD
    DEVELOPMENTAL NEUROPSYCHOLOGY, 1999, 16 (01) : 101 - 115
  • [35] Peripheral venoarterial extracorporeal membrane oxygenation for severe hyperlactataemia after cardiac surgery: a pilot study
    Biesenbach, Peter
    Ghanpur, Rashmi
    Martensson, Johan
    Crisman, Marco
    Lindstrom, Steven
    Hilton, Andrew
    Matalanis, George
    Bellomo, Rinaldo
    CRITICAL CARE AND RESUSCITATION, 2017, 19 (03) : 274 - 279
  • [36] Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data
    Julien Massol
    Noémie Simon-Tillaux
    Joanna Tohme
    Geoffroy Hariri
    Pauline Dureau
    Baptiste Duceau
    Lisa Belin
    David Hajage
    Yann De Rycke
    Ahmed Charfeddine
    Guillaume Lebreton
    Alain Combes
    Adrien Bouglé
    Critical Care, 27
  • [37] Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data
    Massol, Julien
    Simon-Tillaux, Noemie
    Tohme, Joanna
    Hariri, Geoffroy
    Dureau, Pauline
    Duceau, Baptiste
    Belin, Lisa
    Hajage, David
    De Rycke, Yann
    Charfeddine, Ahmed
    Lebreton, Guillaume
    Combes, Alain
    Bougle, Adrien
    CRITICAL CARE, 2023, 27 (01)
  • [38] PNEUMONIA TREATED BY EXTRACORPOREAL MEMBRANE OXYGENATION
    PONTOPPIDAN, H
    MARK, EJ
    PECK, AG
    ZAPOL, WM
    HALES, CA
    CARVALHO, AC
    DRINKER, PA
    KAZEMI, H
    JACOBY, GA
    KITZ, RJ
    GREENE, RE
    BRADLEY, RD
    HAYES, HR
    RIE, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (22): : 1174 - 1181
  • [40] Veno-Venous Extracorporeal Membrane Oxygenation Post Cardiac Surgery
    Ferrara, Antonella
    Bosco, Paolo
    Fowles, Jo-Anne
    Vuylsteke, Alain
    DeSilva, Ravi
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 27 - 27